1.
Kardiologiia
; 33(6): 26-8, 1993.
Article
in Russian
| MEDLINE
| ID: mdl-8397313
Subject(s)
Dietary Fiber/therapeutic use , Galactans/therapeutic use , Gemfibrozil/therapeutic use , Hypercholesterolemia/therapy , Mannans/therapeutic use , Adult , Aged , Combined Modality Therapy , Dietary Fiber/adverse effects , Double-Blind Method , Galactans/adverse effects , Gemfibrozil/adverse effects , Humans , Hypercholesterolemia/blood , Lipids/blood , Lipoproteins/blood , Lipoproteins/drug effects , Male , Mannans/adverse effects , Middle Aged , Plant Gums , Time Factors
2.
Grudn Khir
; (5): 19-23, 1987.
Article
in Russian
| MEDLINE
| ID: mdl-3500896
3.
Grudn Khir
; (1): 20-5, 1987.
Article
in Russian
| MEDLINE
| ID: mdl-3493954
4.
Farmakol Toksikol
; 49(5): 74-6, 1986.
Article
in Russian
| MEDLINE
| ID: mdl-3770181
ABSTRACT
It was found that a hypotensive effect of penbutolol used for treatment of 234 patients with hypertensive disease exceeded that of propranolol and developed at a dose of 20-80 mg a day at the end of the 2nd week of treatment. Penbutolol produces a less negative chronotropic effect as compared to propranolol. The excess of penbutolol therapeutic dose leads to the further augmentation of a positive clinical effect.
Subject(s)
Hypertension/drug therapy , Penbutolol/therapeutic use , Propanolamines/therapeutic use , Adult , Aged , Drug Evaluation , Female , Hemodynamics/drug effects , Humans , Hypertension/physiopathology , Male , Middle Aged , Propranolol/therapeutic use , Random Allocation
5.
Ter Arkh
; 56(11): 94-9, 1984.
Article
in Russian
| MEDLINE
| ID: mdl-6523399